(Circulation. 1996;94:2369-2372.)
© 1996 American Heart Association, Inc.
Articles |
the Statistical Consultation and Research Center and Department of Preventive Medicine (S.P.A., D.Q., W.J.M., H.N.H.), the Atherosclerosis Research Unit and Department of Medicine (C.-R.L., C.-H.L., H.N.H.), and the Department of Molecular Pharmacology and Toxicology (A.S., H.N.H.), University of Southern California, Los Angeles, and the Jet Propulsion Laboratory, California Institute of Technology, Pasadena, Calif (R.H.S.).
Correspondence to Howard N. Hodis, MD, Atherosclerosis Research Unit, Division of Cardiology, University of Southern California School of Medicine, 2250 Alcazar St, CSC 132, Los Angeles CA 90033.
Background There is accumulating experimental, epidemiological, and clinical evidence of an association between antioxidant vitamin intake and reduced risk of coronary heart disease. Using data from the Cholesterol Lowering Atherosclerosis Study (CLAS), we explored the association of self-selected supplementary antioxidant vitamin intake on the rate of progression of early preintrusive atherosclerosis.
Methods and Results CLAS was an arterial imaging trial in which nonsmoking 40- to 59-year-old men with previous coronary artery bypass graft surgery were randomized to colestipol/niacin plus diet or placebo plus diet. The rate of progression of early preintrusive atherosclerosis was determined in 146 subjects using high-resolution B-mode ultrasound quantification of the distal common carotid artery far wall intima-media thickness (IMT). From the nutritional supplement database, 22 subjects had an on-trial average supplementary vitamin E intake of
100 IU per day (high users) and 29 subjects had an average on-trial supplementary vitamin C intake of
250 mg per day (high users). Within the placebo group, less carotid IMT progression was found for high supplementary vitamin E users when compared with low vitamin E users (0.008 versus 0.023 mm/y, P=.03). No effect of vitamin E within the drug group was found. No effect of vitamin C within the drug or placebo group was found.
Conclusions Supplementary vitamin E intake appears to be effective in reducing the progression of atherosclerosis in subjects not treated with lipid-lowering drugs while the process is still confined to the arterial wall (early preintrusive atherosclerosis).
Key Words: antioxidants atherosclerosis carotid arteries
This article has been cited by other articles:
![]() |
J. Tkac, S. F. P. Man, and D. D. Sin Review: Systemic consequences of COPD Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 47 - 59. [Abstract] [PDF] |
||||
![]() |
H. Chen, R. J. Karne, G. Hall, U. Campia, J. A. Panza, R. O. Cannon III, Y. Wang, A. Katz, M. Levine, and M. J. Quon High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H137 - H145. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Greaves and S. Gordon Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors J. Lipid Res., January 1, 2005; 46(1): 11 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Bots, G. W. Evans, W. A. Riley, and D. E. Grobbee Carotid Intima-Media Thickness Measurements in Intervention Studies: Design Options, Progression Rates, and Sample Size Considerations: A Point of View Stroke, December 1, 2003; 34(12): 2985 - 2994. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Earnest, K. A. Wood, and T. S. Church Complex Multivitamin Supplementation Improves Homocysteine and Resistance to LDL-C Oxidation J. Am. Coll. Nutr., October 1, 2003; 22(5): 400 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Salonen, K. Nyyssonen, J. Kaikkonen, E. Porkkala-Sarataho, S. Voutilainen, T. H. Rissanen, T.-P. Tuomainen, V.-P. Valkonen, U. Ristonmaa, H.-M. Lakka, et al. Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study Circulation, February 25, 2003; 107(7): 947 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gross, X. Yu, P. Hannan, C. Prouty, and D. R Jacobs Jr Lipid standardization of serum fat-soluble antioxidant concentrations: the YALTA study Am. J. Clinical Nutrition, February 1, 2003; 77(2): 458 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. O'Neal, G. Dragicevic, K. G. Rowley, M. Z. Ansari, N. Balazs, A. Jenkins, and J. D. Best A Cross-Sectional Study of the Effects of Type 2 Diabetes and Other Cardiovascular Risk Factors on Structure and Function of Nonstenotic Arteries of the Lower Limb Diabetes Care, January 1, 2003; 26(1): 199 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Schwenke, L. L. Rudel, M. G. Sorci-Thomas, and M. J. Thomas {alpha}-Tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits J. Lipid Res., November 1, 2002; 43(11): 1927 - 1938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Crouse III, R. Tang, M. A. Espeland, J. G. Terry, T. Morgan, and M. Mercuri Associations of Extracranial Carotid Atherosclerosis Progression With Coronary Status and Risk Factors in Patients With and Without Coronary Artery Disease Circulation, October 15, 2002; 106(16): 2061 - 2066. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Hodis, W. J. Mack, L. LaBree, P. R. Mahrer, A. Sevanian, C.-r. Liu, C.-h. Liu, J. Hwang, R. H. Selzer, S. P. Azen, et al. Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS) Circulation, September 17, 2002; 106(12): 1453 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iannuzzi, E. Celentano, S. Panico, R. Galasso, G. Covetti, L. Sacchetti, F. Zarrilli, M. De Michele, and P. Rubba Dietary and circulating antioxidant vitamins in relation to carotid plaques in middle-aged women Am. J. Clinical Nutrition, September 1, 2002; 76(3): 582 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Jarvik, N. T. Tsai, L. A. McKinstry, R. Wani, V. H. Brophy, R. J. Richter, G. D. Schellenberg, P. J. Heagerty, T. S. Hatsukami, and C. E. Furlong Vitamin C and E Intake Is Associated With Increased Paraoxonase Activity Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1329 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Chambless, A. R. Folsom, V. Davis, R. Sharrett, G. Heiss, P. Sorlie, M. Szklo, G. Howard, and G. W. Evans Risk Factors for Progression of Common Carotid Atherosclerosis: The Atherosclerosis Risk in Communities Study, 1987-1998 Am. J. Epidemiol., January 1, 2002; 155(1): 38 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. RICCIARELLI, J.-M. ZINGG, and A. AZZI Vitamin E: protective role of a Janus molecule FASEB J, November 1, 2001; 15(13): 2314 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R Gale, H. E Ashurst, H. J Powers, and C. N Martyn Antioxidant vitamin status and carotid atherosclerosis in the elderly Am. J. Clinical Nutrition, September 1, 2001; 74(3): 402 - 408. [Abstract] [Full Text] |
||||
![]() |
N. Ishizaka, Y. Ishizaka, E. Takahashi, M. Yamakado, and H. Hashimoto High Serum Bilirubin Level Is Inversely Associated With the Presence of Carotid Plaque Stroke, February 1, 2001; 32 (2): 580 - 583. [Full Text] [PDF] |
||||
![]() |
N. Kaul, S. Devaraj, and I. Jialal {{alpha}}-Tocopherol and Atherosclerosis Experimental Biology and Medicine, January 1, 2001; 226(1): 5 - 12. [Abstract] [Full Text] |
||||
![]() |
D. Altavilla, B. Deodato, G. M. Campo, M. Arlotta, M. Miano, G. Squadrito, A. Saitta, D. Cucinotta, S. Ceccarelli, M. Ferlito, et al. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-{kappa}B and reduces the inflammatory response in myocardial ischemia-reperfusion injury Cardiovasc Res, August 18, 2000; 47(3): 515 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. P. Skyrme-Jones, R. C. O'Brien, K. L. Berry, and I. T. Meredith Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study J. Am. Coll. Cardiol., July 1, 2000; 36(1): 94 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ascherio, E. B. Rimm, M. A. Hernan, E. Giovannucci, I. Kawachi, M. J. Stampfer, and W. C. Willett Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States Ann Intern Med, June 15, 1999; 130(12): 963 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Tribble Antioxidant Consumption and Risk of Coronary Heart Disease: Emphasis on Vitamin C, Vitamin E, and ß-Carotene : A Statement for Healthcare Professionals From the American Heart Association Circulation, February 2, 1999; 99(4): 591 - 595. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |